Study of a New Microcatheter, the Corsair Pro SC, for Treatment of Blocked Arteries in the Heart

Not Applicable

Conditions: Coronary artery disease
Cardiovascular - Coronary heart disease

Registration Number: ACTRN12624000999538

Lead Sponsor: Professor Scott Harding

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot yet recruiting

Sex: All

Target Recruitment: 9

Inclusion Criteria

For inclusion in the study participants are required fulfil the following criteria:
1.18 years or older
2.Patients undergoing PCI for CTO.

Exclusion Criteria

Participants should not enter the study if any of the following exclusion criteria are fulfilled:
•Those presenting for primary PCI with ST-segment-elevation Myocardial Infarction (STEMI)
•Dual antithrombotic therapy is contraindicated
•Inability to give informed consent

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Successful crossing of the CTO with a coronary guide wire[Assessed by coronary angiography using x-ray images Outcome will be assess upon completion of the PCI]

Secondary Outcome Measures

Name	Time	Method
MACE (composite of cardiovascular death, myocardial infarction, or target vessel revascularisation)[Clinical follow-up through review of medical records and telephone follow-up. 30 days post PCI];Technical success (Thrombolysis in Myocardial Infarction (TIMI) grade 2 or greater flow with <30% residual stenosis of the target CTO lesion).[Angiographic review using X-ray images) Upon completion of the index PCI];Procedural success (technical success without MACE)[Angiographic review using X-ray, clinical review of the patient and review of medical records At hospital discharge, at 7 days post PCI or death, which ever occurs first.]